Study of hiv persistence and reservoir
Part of Infections clinical trials.
This study looks at how HIV persists in the body and how the virus behaves over time. It may help researchers better understand how to improve HIV treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be living with HIV
- You must be 18 years of age or older
- You must have social insurance (health coverage)
- You must be able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This is an observational study that follows people to better understand how HIV and other infections (like sexually transmitted infections) happen and change over time. It may help researchers improve prevention and care, but it is mainly for monitoring rather than testing a new treatment.
This study looks at how the immune system and HIV behave in people on long-term HIV treatment (ART), using blood samples that will be stored for future tests for up to 20 years. It may help researchers understand how well treatment is controlling HIV and improve future care.
This study looks at how certain immune cells (NK cells) behave in people who have been on HIV treatment for a long time. It aims to understand why some people's immune systems respond differently, which could help improve future treatments.
This study compares how active the immune system is and how large the “hidden” HIV reservoir is in people on two different HIV treatment types. It may help researchers understand whether staying on a tenofovir-containing regimen leads to better control of HIV hiding in the body.
This study looks at the hidden virus and immune system in people living with HIV who can control the virus without medication or after certain treatments. It aims to understand why some people control HIV better, which could lead to new treatments.
This is an observational study (not a new drug) that tracks how living with HIV can change over time in different treatment situations. It may help researchers understand long-term effects of the modern “protease inhibitor era” and improve future care.
Hear when a new HIV Infected Individuals trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.